Express Scripts Holding Co. (NASDAQ: ESRX) shares gained 1.1% to $81.86, as the largest manager of U.S. prescription-drug benefits decided an AbbVie drug will be its exclusive option for treating the most common form of hepatitis C. Share volume was 950,000, compared to an all-day average of 3.7 million
